These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3105117)

  • 21. Characterization of genetic defects in macrophage tumoricidal capacity: identification of murine strains with abnormalities in secretion of cytolytic factors and ability to bind neoplastic targets.
    Adams DO; Marino PA; Meltzer MS
    J Immunol; 1981 May; 126(5):1843-7. PubMed ID: 6783698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum containing tumor necrosis factor is cytotoxic for the human malaria parasite Plasmodium falciparum.
    Haidaris CG; Haynes JD; Meltzer MS; Allison AC
    Infect Immun; 1983 Oct; 42(1):385-93. PubMed ID: 6352501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intratumor immunochemotherapy with 5-fluorouracil emulsion and BCG in C3H/HE mice transplanted with MH134.
    Sakita M; Kasuga M; Yamane T; Torii T; Imai H; Kageyama N; Fujita Y; Majima S
    Gan; 1982 Dec; 73(6):931-7. PubMed ID: 6761229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of macrophage antitumor activity by a mycobacterial fraction. In vivo and in vitro studies.
    Rashid G; Gittel H; Ben-Efraim S
    Anticancer Res; 1994; 14(3A):1083-7. PubMed ID: 8074454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BCG-induced enhancement of endotoxin sensitivity in C3H/HeJ mice. I. In vivo studies.
    Vogel SN; Moore RN; Sipe JD; Rosenstreich DL
    J Immunol; 1980 Apr; 124(4):2004-9. PubMed ID: 6154089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antitumor effects of bacterial lipopolysaccharide and tumor necrosis factor in mice].
    Moriya N
    Nihon Geka Gakkai Zasshi; 1985 Nov; 86(11):1470-9. PubMed ID: 3908902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BCG immunopotentiation of an antitumor response: evidence for a cell-mediated mechanism.
    Hawrylko E
    J Natl Cancer Inst; 1975 Aug; 55(2):413-23. PubMed ID: 808641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antitumor effects of recombinant BCG and interleukin-12 DNA vaccines on xenografted murine bladder cancer.
    Yu DS; Lee CF; Hsieh DS; Chang SY
    Urology; 2004 Mar; 63(3):596-601. PubMed ID: 15028475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in biological activity among batches of lyophilized tice Bacillus Calmette-Guérin and their association with clinical course in Stage I lung cancer.
    Bennett JA; Gruft H; McKneally MF; Zelterman D; Crispen RG
    Cancer Res; 1983 Sep; 43(9):4183-90. PubMed ID: 6347367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endogenous production of TNF in mice long after BCG sensitization.
    Satoh M; Inagawa H; Minagawa H; Kajikawa T; Oshima H; Abe S; Yamazaki M; Mizuno D
    J Biol Response Mod; 1986 Apr; 5(2):117-23. PubMed ID: 3525760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mammary tumor growth inhibition in C3H/He mice by long-term Bacillus Calmette-Guérin immunoprophylaxis versus enhancement by primary Bacillus Calmette-Guérin therapy.
    Vaage J
    Cancer Res; 1983 Dec; 43(12 Pt 1):5778-82. PubMed ID: 6357431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antitumor effect of bacterial lipopolysaccharide (LPS) and a combination use of LPS and lentinan on C3H/He mice bearing MH-134 tumor].
    Moriya N; Miwa H; Taketsuka S; Orita K
    Gan To Kagaku Ryoho; 1983 Jul; 10(7):1646-52. PubMed ID: 6870308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergistic antitumor effects of BCG and monoclonal antibodies capable of inducing antibody-dependent cell-mediated cytotoxicity.
    Komuta K; Kawase I; Ogura T; Masuno T; Yokota S; Hosoe S; Ikeda T; Shirasaka T; Kishimoto S
    Jpn J Cancer Res; 1987 Feb; 78(2):185-92. PubMed ID: 3104261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-estrogens potentiate the immunotherapy of the P815 murine mastocytoma by cytotoxic T lymphocytes.
    Nagy E; Baral E; Kangas L; Berczi I
    Anticancer Res; 1997; 17(2A):1083-8. PubMed ID: 9137453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specificity of the T cells that mediate and suppress adoptive immunotherapy of established tumors.
    Dye ES; North RJ
    J Leukoc Biol; 1984 Jul; 36(1):27-37. PubMed ID: 6234371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Passive local anaphylaxis: demonstration of antitumor activity and complementation of intratumor BCG.
    Lynch NR; Salomon JC
    J Natl Cancer Inst; 1977 Apr; 58(4):1093-8. PubMed ID: 321794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitory effect of bisbenzylisoquinoline alkaloids on the quick death of mice treated with BCG/LPS.
    Kondo Y; Imai Y; Kubota Y; Hojo H; Nozoe S
    Chem Pharm Bull (Tokyo); 1990 Oct; 38(10):2887-9. PubMed ID: 2076579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of cell-wall skeleton of Mycobacterium bovis BCG on cell-mediated cytotoxicity in tumor-bearing mice.
    Taniyama T; Azuma I; Aladin AA; Yamamura Y
    Gan; 1975 Dec; 66(6):705-9. PubMed ID: 817955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Competitive action of a biological response modifier, PSK, on a humoral immunosuppressive factor produced in tumor-bearing hosts.
    Matsunaga K; Morita I; Iijima H; Endo H; Oguchi Y; Yoshimura M; Fujii T; Yoshikumi C; Nomoto K
    J Clin Lab Immunol; 1990 Mar; 31(3):127-36. PubMed ID: 1966997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of Candida solubilized cell wall beta-glucan in antitumor immunotherapy against P815 mastocytoma in mice.
    Tokunaka K; Ohno N; Adachi Y; Miura NN; Yadomae T
    Int Immunopharmacol; 2002 Jan; 2(1):59-67. PubMed ID: 11789670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.